Roth Capital Starts Hanwha Q CELLS (HQCL) at Buy

Roth Capital initiates coverage on Hanwha Q CELLS (NASDAQ: HQCL) with a Buy rating and a price target of $14.00.

Analyst Philip Shen commented, "Backed by Hanwha Corporation (a Fortune Global 500 company), HQCL was formed when Hanwha merged two prior acquisitions—Solarfun and Q CELLS. As a testament to the bankability of the combined entity, management recently inked the industry’s largest single module order with attractive terms (1.5GW, $449mn upfront payment). Underfollowed HQCL is a solar major that is the linchpin member of the family of Hanwha-backed, companies with solar exposure (polysilicon, machinery, materials, EPC, life insurance). Initiating at Buy, $14PT."

For an analyst ratings summary and ratings history on Hanwha Q CELLS click here. For more ratings news on Hanwha Q CELLS click here.

Shares of Hanwha Q CELLS closed at $9.32 yesterday.

You May Also Be Interested In

• Oppenheimer Downgrades Legend Biotech Corp. (LEGN) to Perform, 'CEO/Partnership/Competition Overhangs to Cap Upside'
• Vestis Corp (VSTS) PT Raised to $14 at Stifel as Operational Turnaround Progresses
• Expand Energy (EXE) PT Lowered to $109 at Benchmark